ABSTRACT
To adapt the ‘Personal Evaluation of Transitions in Treatment (PETIT)’ scale into Spanish and analyse its psychometric properties on schizophrenic population.
Subject(s)
Schizophrenia , Humans , Psychometrics , Schizophrenia/therapy , Surveys and Questionnaires , TranslationsABSTRACT
Objetivo. Adaptar al español la escala Personal Evaluation of Transitions in Treatment (PETIT) y analizar sus propiedades psicométricas en población con esquizofrenia. Metodología. Participaron 223 pacientes en tratamiento ambulatorio con diagnóstico de esquizofrenia según criterios DSM-5. Se utilizaron como gold estándar la variable cumplimiento terapéutico, DAI10 y SMAQ y se analizaron las propiedades psicométricas de la escala en tres momentos (basal, al mes y 6 meses). Resultados. La validez de apariencia (lógica) de la escala es muy elevada. En el análisis factorial exploratorio identificamos que sería necesario eliminar el ítem-7. La fiabilidad de la escala es alta con un alfa-Cronbach de 0,91 demostrando buena consistencia interna. El análisis factorial confirmatorio tras eliminar el ítem-7 obtiene 5 componentes que explican el 57,76% de la varianza. El contenido de la escala es válido para discriminar pacientes con diferente adherencia, respuesta al tratamiento y calidad de vida. El punto de corte de la escala PETIT en español se establece en 24 puntos para ambos sexos; presentando una buena sensibilidad al cambio, y una fuerza de concordancia muy buena para los tres momentos evaluados. Conclusiones. La escala PETIT tras eliminar el ítem7 y utilizando 24 como punto de corte permite detectar cambios en la adherencia al tratamiento, su respuesta y las modificaciones resultantes en la calidad de vida de los pacientes. Su uso como único instrumento que mide todo lo anterior lo hace recomendable en la práctica clínica ya que esta precisa de métodos de evaluación sencillos que no consuman grandes esfuerzos o tiempo.(AU)
Aims. To adapt the Personal Evaluation of Transitions in Treatment (PETIT) scale into Spanish and analyse its psychometric properties on schizophrenic population. Method. 223 patients in outpatient treatment diagnosed with schizophrenia according to DSM-5 criteria participated in the study. A defined variable therapeutic compliance, DAI10 and SMAQ were used as a gold standard and the psychometric properties of the scale were analysed at three time points (baseline, 1 month and 6 months). Results. The scale has very high face (or logical) validity. Exploratory factor analysis showed it would be necessary to eliminate item 7. The reliability of the scale is high (Cronbachs alpha = 0.91), demonstrating good internal consistency. After eliminating item 7, confirmatory factor analysis obtained 5 components that explained 57,76% of the variance. The content of the scale is valid for discriminating between patients of different treatment adherence, response and quality of life. The cut-off point of the PETIT scale in Spanish is set at 24 points for both sexes, with good sensibility to change and very good concordance force over the three time points evaluated. Conclusions. After eliminating item 7 and using 24 as cut-off point, the PETIT scale was able to detect changes in both adherence and response to treatment as well as the resulting modifications to the quality of life of patients. Its use as a single instrument to measure all of the above makes it advisable for use in clinical practice, as the evaluationmethods it requires are relatively simple and quick to perform.(AU)
Subject(s)
Humans , Health Sciences , Schizophrenia , Treatment Adherence and Compliance , Psychometrics , Quality of Life , OutpatientsABSTRACT
AIMS: Assess the prevalence of dual pathology in patients with alcohol dependence and describe the psychopathological profile of mental disorders, impulsiveness, ADHD presence and craving. METHOD: It is a cross-sectional study about dual pathology, carried out on 102 patients undergoing outpatient treatment. The presence of dual pathology is established by means of the MINI-5 interview and the MCMI-III test; DSM-IV being used as the alcohol abuse criteria. Impulsiveness, ADHD presence, craving and quality of life were measured through SIS, ASRSv1, MACS and SF-36. RESULTS: The prevalence of dual pathology ranges from 45.1% to 80.4% according to MCMI-III and MINI-5, respectively. The most frequent pathologies are current major depressive episodes, followed by current generalized anxiety disorders, suicide risk and current dysthymia disorders; 73.2% of dual patients present a moderate and intense global score according to MACS, 56.1% got a meaningful score in impulsiveness according to SIS and 41.5% has highly consistent symptoms with ADHD. As regards quality of life, 53.7% of the sample had bad mental health. In the case of dual patients consuming other substances, 30% had a history of bipolar disorders and 10% had a high suicide risk. CONCLUSIONS: The prevalence of psychiatric comorbidity in patients with alcohol dependence undergoing outpatient treatment varies depending on the detection method, MINI being the one identifying a greater number of cases. More than half of dual patients present impulsive behavior, a bad mental health state and high craving levels. Special attention should be paid to dual patients consuming other substances.
Subject(s)
Alcoholism/epidemiology , Alcoholism/psychology , Mental Disorders/epidemiology , Mental Disorders/psychology , Adult , Aged , Ambulatory Care , Cross-Sectional Studies , Diagnosis, Dual (Psychiatry) , Female , Humans , Male , Middle Aged , PrevalenceABSTRACT
Objetivo. Estimar la prevalencia de patología dual (PD) en pacientes con dependencia alcohólica y describir el perfil psicopatológico de los trastornos mentales, su impulsividad, hiperactividad y craving. Metodología. Estudio transversal sobre PD de 102 pacientes en tratamiento ambulatorio. Se determina la presencia de PD mediante la entrevista MINI-5 y el test MCMI-III, utilizando como criterio de abuso o dependencia de alcohol el DSM-IV. Se emplearon además la EIE (impulsividad), ASRSv1 (hiperactividad), EMCA (craving) y SF-36 (calidad de vida). Resultados. La prevalencia de PD varía del 45,1% (MCMI-III) al 80,4% (MINI-5) dependiendo del instrumento utilizado. Predominan el episodio depresivo mayor actual y recidivante, seguido por el trastorno de ansiedad generalizada actual, el riesgo de suicidio y el trastorno distímico actual; el 73,2% de los pacientes duales presenta una puntuación global moderada-intensa en EMCA, un 56,1% tiene conducta impulsiva y un 41,5% síntomas altamente consistentes con el TDAH. Respecto a la calidad de vida, el 53,7% tenía un mal estado de salud mental. Un 30% de los pacientes con PD y consumo añadido de drogas tenía antecedentes de trastorno bipolar y un 10% riesgo de suicidio alto. Conclusiones. La prevalencia de comorbilidad psiquiátrica en pacientes con dependencia alcohólica en tratamiento ambulatorio varía dependiendo del método de detección, siendo la MINI la que identifica un mayor número de casos. Más de la mitad de los pacientes con PD tiene conducta impulsiva, mala calidad de salud mental y altos niveles de craving. Requieren especial atención los PD con consumo de otras sustancias
Aims. Assess the prevalence of dual pathology in patients with alcohol dependence and describe the psychopathological profile of mental disorders, impulsiveness, ADHD presence and craving. Method. It is a cross-sectional study about dual pathology, carried out on 102 patients undergoing outpatient treatment. The presence of dual pathology is established by means of the MINI-5 interview and the MCMI-III test; DSM-IV being used as the alcohol abuse criteria. Impulsiveness, ADHD presence, craving and quality of life were measured through SIS, ASRSv1, MACS and SF-36. Results. The prevalence of dual pathology ranges from 45.1% to 80.4% according to MCMI-III and MINI-5, respectively. The most frequent pathologies are current major depressive episodes, followed by current generalized anxiety disorders, suicide risk and current dysthymia disorders; 73.2% of dual patients present a moderate and intense global score according to MACS, 56.1% got a meaningful score in impulsiveness according to SIS and 41.5% has highly consistent symptoms with ADHD. As regards quality of life, 53.7% of the sample had bad mental health. In the case of dual patients consuming other substances, 30% had a history of bipolar disorders and 10% had a high suicide risk. Conclusions. The prevalence of psychiatric comorbidity in patients with alcohol dependence undergoing outpatient treatment varies depending on the detection method, MINI being the one identifying a greater number of cases. More than half of dual patients present impulsive behavior, a bad mental health state and high craving levels. Special attention should be paid to dual patients consuming other substances
